Skip to main content

Advertisement

Table 1 Baseline characteristics

From: N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study

Characteristic n = 12
Age (years) 65 ± 11
Male (%) 6 (50)
BMI (kg/m2) 28.2 ± 5.4
SBP (mmHg) 141 ± 7.6
DBP (mmHg) 74.9 ± 11.0
HbA1c (%) 6.9 ± 0.70
FPG (mg/dL) 139.5 ± 40.5
TC (mg/dL) 176.4 ± 26.8
LDL-C (mg/dL) 97.3 ± 25.8
HDL-C (mg/dL) 45.5 ± 9.1
TG (mg/dL) 184.7 ± 34.8
EPA/AA 0.30 ± 0.19
DHA/AA 0.75 ± 0.16
AST (IU/L) 24.5 ± 13.0
ALT (IU/L) 32.5 ± 31.7
Cre (mg/dL) 0.81 ± 0.30
Antidiabetic medications (%)  
 DPP-4 inhibitor 12 (100)
 Metformin 6 (50)
 Glimepiride 3 (25)
 Repaglinide 1 (8.3)
 Miglitol 3 (25)
 Ipragliflozin 1 (8.3)
 Insulin Aspart 2 (16.6)
 Insulin Detemir 1 (8.3)
 Insulin Glargine 1 (8.3)
Hypolipidemic agents  
 Rosuvastatin 6 (50)
 Atorvastatin 2 (16.6)
 Pravastatin 2 (16.6)
 Pitavastatin 2 (16.6)
Antihypertensive agents 9 (75)
Microvascular complications  
 Diabetes nephropathy 3 (25)
Macrovascular complications  
 Cerebral infarction 1 (8.3)
  1. Data represent the means ± standard deviation or n (%). BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HbA1c glycated hemoglobin, FPG fasting plasma glucose, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglyceride, AST aspartate aminotransferase, ALT alanine aminotransferase, Cre creatinine